NEW YORK (GenomeWeb) – NeoGenomics has commenced an underwritten public offering of approximately $125 million of newly issued shares of common stock.

The company intends to grant underwriters a 30-day option to purchase up to an aggregate of an additional 15 percent of the shares offered in the public offering.